ITABMED
ITabMed is a clinical-stage biotech company located in Shanghai, China. The company was founded in 2020 and is registered in Lin Gang Sci-Tech City, Shanghai. It was a spin-off entity from the former “Generon BioMed Ltd.”. The company is focused on immunotherapy drug research and development to treat cancer.
ITABMED
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2020-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.itabmed.com
Status:
Active
Contact:
021-20907805
Email Addresses:
[email protected]
Total Funding:
20 M USD
Technology used in webpage:
SPF Apache Pound Sterling DMARC HiChina DNS Dingfeng Xinhui
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Current Employees Featured
Founder
Investors List
Regent Capital
Regent Capital investment in Series A - ITabMed
3E Bioventures
3E Bioventures investment in Series A - ITabMed
Binhai Capital
Binhai Capital investment in Series A - ITabMed
Yongjin Group
Yongjin Group investment in Series A - ITabMed
Official Site Inspections
http://www.itabmed.com
- Host name: 107.150.123.218
- IP address: 107.150.123.218
- Location: Central Hong Kong
- Latitude: 22.2909
- Longitude: 114.15
- Timezone: Asia/Hong_Kong
